|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| A61K 31/4709 | (2006.01) | ||
| A61P 7/00 | (2006.01) |
| (11) | Number of the document | 1815247 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05851365.6 |
| Date of filing the European patent application | 2005-11-02 | |
| (97) | Date of publication of the European application | 2007-08-08 |
| (45) | Date of publication and mention of the grant of the patent | 2013-02-20 |
| (46) | Date of publication of the claims translation | 2013-06-25 |
| (86) | Number | PCT/US2005/039948 |
| Date | 2005-11-02 |
| (87) | Number | WO 2006/052718 |
| Date | 2006-05-18 |
| (30) | Number | Date | Country code |
| 625204 P | 2004-11-05 | US | |
| 708075 P | 2005-08-12 | US |
| (72) |
FOURIE, Anne, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Farneziltransferazės inhibitorių terapinis panaudojimas ir jų veiksmingumo stebėsenos būdai |
| THERAPEUTIC USE OF FARNESYLTRANSFERASE INHIBITORS AND METHODS OF MONITORING THE EFFICACY THEREOF |
| Payment date | Validity (years) | Amount | |
| 2023-10-19 | 19 | 347.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-11-02 |